Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases

R. J. Cote, P. P. Rosen, M. L. Lesser, L. J. Old, M. P. Osborne

Research output: Contribution to journalArticle

420 Scopus citations

Abstract

We used monoclonal antibodies to identify occult micrometastases in the bone marrow of 49 patients with operable (stage I and II) breast carcinoma. Follow-up (mean, 29 months; median, 30 months) revealed that 12 patients recurred. The presence of bone marrow micrometastases (BMM) was significantly associated with early recurrence (P < .04). The estimated 2-year recurrence rate for patients with no BMM detected (BMM-) was 3%; in patients with BMM, the 2-year recurrence rate was 33%. When BMM and axillary lymph node (LN) status were combined, groups of patients at low risk (LN-, BMM-; 2-year recurrence rate, 0%) and high risk (LN+, BMM+; 2-year recurrence rate, 42%) for early recurrence were identified. Bone marrow tumor burden was related to early recurrence. Among patients with BMM, those who did not recur had on average fewer extrinsic cells in their marrow than those who recurred (15 v 43 cells, respectively). Multivariate analysis comparing BMM, LN+ versus LN-, and tumor size (≤ 2 cm v > 2 cm) revealed no factor independently associated with early recurrence. Peripheral tumor burden of BMM (0 or < 10 extrinsic cells v ≥ 10 extrinsic cells) was the only independent predictor of early recurrence (P < .003). In conjunction with conventional prognostic factors, particularly axillary LN status, evaluation for BMM might be used to stratify patients for adjuvant treatment programs. Because this pilot study involved few patients with short-term follow-up, the results should be interpreted with caution. The examination of bone marrow for micrometastases remains an experimental procedure; the clinical usefulness of the test will be established through larger studies with long-term follow-up.

Original languageEnglish
Pages (from-to)1749-1756
Number of pages8
JournalJournal of Clinical Oncology
Volume9
Issue number10
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint Dive into the research topics of 'Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases'. Together they form a unique fingerprint.

  • Cite this